Middle East & Africa Deep Brain Stimulation Devices Market Size & Outlook
Related Markets
MEA deep brain stimulation devices market highlights
- The MEA deep brain stimulation devices market generated a revenue of USD 46.2 million in 2024.
- The market is expected to grow at a CAGR of 13.9% from 2025 to 2033.
- In terms of segment, dual-channel was the largest revenue generating product in 2024.
- Single-channel is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2033.
MEA data book summary
| Market revenue in 2024 | USD 46.2 million |
| Market revenue in 2033 | USD 152.2 million |
| Growth rate | 13.9% (CAGR from 2025 to 2033) |
| Largest segment | Dual-channel |
| Fastest growing segment | Single-channel |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dual-channel, Single-channel |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.3% of the global deep brain stimulation devices market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 426.2 million by 2033.
Dual-channel was the largest segment with a revenue share of 68.61% in 2024. Horizon Databook has segmented the Middle East & Africa deep brain stimulation devices market based on dual-channel, single-channel covering the revenue growth of each sub-segment from 2021 to 2033.
The MEA region includes South Africa, Saudi Arabia, UAE, and other countries. Increase in incidence of neurological diseases, such as Alzheimer's disease, dementia, and PD, is contributing to the market growth.
In May 2017, Global Plan of Action on Dementia developed by WHO has been adopted at World Health Assembly in Geneva to create awareness about dementia and increase funding for neology hospitals. Thus, government efforts coupled with developing healthcare infrastructure in the region is expected to further fuel growth of the market in the region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| NeuroPace Inc | View profile | 181 | 455 N. Bernardo Avenue, Mountain View, CA, United States, 94043 | https://www.neuropace.com |
| Nexstim Oyj Registered Shs Reg S | View profile | 37 | Elimaenkatu 9 B, Helsinki, Finland, FI-00510 | https://www.nexstim.com |
| LivaNova PLC | View profile | 2900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | https://www.livanova.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
MEA deep brain stimulation devices market size, by country, 2021-2033 (US$M)
Middle East & Africa Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
